Zobrazeno 1 - 4
of 4
pro vyhledávání: '"TRAMONTI, Stefano"'
Autor:
Cavazzoni, Andrea, Bonelli, Mara A., Fumarola, Claudia *, La Monica, Silvia, Airoud, Kinda, Bertoni, Ramona, Alfieri, Roberta R., Galetti, Maricla, Tramonti, Stefano, Galvani, Elena, Harris, Adrian L., Martin, Lesley-Ann, Andreis, Daniele, Bottini, Alberto, Generali, Daniele, Petronini, Pier Giorgio
Publikováno v:
In Cancer Letters 1 October 2012 323(1):77-87
Autor:
TRAMONTI, Stefano
Publikováno v:
Pallas, 1996 Jan 01(44), 101-107.
Externí odkaz:
https://www.jstor.org/stable/43605379
Autor:
Alfieri Roberta R, Galetti Maricla, Tramonti Stefano, Andreoli Roberta, Mozzoni Paola, Cavazzoni Andrea, Bonelli Mara, Fumarola Claudia, La Monica Silvia, Galvani Elena, De Palma Giuseppe, Mutti Antonio, Mor Marco, Tiseo Marcello, Mari Ettore, Ardizzoni Andrea, Petronini Pier
Publikováno v:
Molecular Cancer, Vol 10, Iss 1, p 143 (2011)
Abstract Background Gefitinib is a tyrosine kinase inhibitor (TKI) of the epidermal growth factor receptor (EGFR) especially effective in tumors with activating EGFR gene mutations while EGFR wild-type non small cell lung cancer (NSCLC) patients at p
Externí odkaz:
https://doaj.org/article/36c158519ce04c369436c2a28f902f1b
Autor:
Pier Giorgio Petronini, Daniele Andreis, Maricla Galetti, Adrian L. Harris, Daniele Generali, Stefano Tramonti, Elena Galvani, Andrea Cavazzoni, Lesley-Ann Martin, Claudia Fumarola, Alberto Bottini, Silvia La Monica, Roberta Alfieri, Kinda Airoud, Mara A. Bonelli, Ramona Bertoni
Publikováno v:
Cancer Letters. 323(1)
Development of resistance to endocrine therapy is a clinical issue in estrogen receptor (ER)-positive breast cancer. Here we show that persistent activation of AKT/mTOR signaling is crucial to the acquisition of letrozole resistance in cell clones ge